PLAC4 antibody (N-Term)
Quick Overview for PLAC4 antibody (N-Term) (ABIN954166)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 19-48, N-Term
-
Specificity
- This antibody recognizes PLAC4 at N-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the N-terminal region (between 19-48aa) of human PLAC4.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PLAC4 (Placenta-Specific 4 (PLAC4))
-
Alternative Name
- PLAC4
-
Background
- PLAC4 (placenta-specific protein 4), was initially discovered as a gene whose mRNA was expressed in placental syncytiotrophoblast and choriocarcinoma cells. While the function of PLAC4 is currently unclear, its gene is known to be located on chromosome 21q22.3. Due to the PLAC4 gene location on chromosome 21 and the release of its mRNA transcripts into maternal bloodstream from the placenta, it has been proposed to be a useful marker noninvasive prenatal chromosome 21 aneuploidy detection, although other reports suggests that PLAC4 mRNA levels are not altered in the maternal circulation of pregnancies with trisomy 21.Synonyms: C21orf115, D21S418E, Placenta-specific protein 4
-
Gene ID
- 191585
-
NCBI Accession
- NP_878252
Target
-